back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-04-17 Tx date 2018-04-12 |
$LILY
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.32; Expiry: April 15, 2020
16 - Acquisition or disposition under a prospectus exemption
|
+50,000 vol |
50,000 | |
| Filed 2018-04-17 Tx date 2018-04-12 |
$LILY
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+50,000 vol |
333,709 | |
| Filed 2018-04-17 Tx date 2018-04-12 |
$LILY
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 10% per annum; due April 15, 2020
16 - Acquisition or disposition under a prospectus exemption
|
+$12,500 vol |
$12,500 | |
| Filed 2018-04-17 Tx date 2014-12-02 |
$LILY
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.32; Expiry: April 15, 2020
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-17 Tx date 2018-04-12 |
$LILY
Callitas Health Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+60,000 vol |
64,000 | |
| Filed 2018-04-17 Tx date 2018-04-12 |
$LILY
Callitas Health Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+12,000 vol |
76,000 | |
| Filed 2018-04-17 Tx date 2015-05-14 |
$LILY
Callitas Health Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 10% per annum; due April 15, 2020
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-17 Tx date 2018-04-12 |
$LILY
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+10,000 vol |
343,709 | |
| Filed 2018-04-17 Tx date 2018-04-12 |
$LILY
Callitas Health Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 10% per annum; due April 15, 2020
16 - Acquisition or disposition under a prospectus exemption
|
+$15,000 vol |
$15,000 | |
| Filed 2018-04-17 Tx date 2015-05-14 |
$LILY
Callitas Health Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.32; Expiry: April 15, 2020
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-17 Tx date 2018-04-12 |
$LILY
Callitas Health Inc. |
Andrews, Christopher Norman
4 - Director of Issuer
Direct Ownership
|
Warrants at an exercise price of $0.32; Expiry: April 15, 2020
16 - Acquisition or disposition under a prospectus exemption
|
+60,000 vol |
60,000 | |
| Filed 2018-04-16 Tx date 2018-04-12 |
$LILY
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 10% per annum; due April 15, 2020
16 - Acquisition or disposition under a prospectus exemption
|
$
+$12,500 vol $1,000 each |
||
| Filed 2018-04-16 Tx date 2018-04-12 |
$LILY
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 10% per annum; due April 15, 2020
16 - Acquisition or disposition under a prospectus exemption
|
$
+$12,500 vol $1,000 each |
||
| Filed 2018-04-16 Tx date 2014-12-02 |
$LILY
Callitas Health Inc. |
Skeith, Donald Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures 10% per annum; due April 15, 2020
00 - Opening Balance-Initial SEDI Report
|